S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy
about
Molecular pathogenesis of pulmonary arterial hypertensionExpression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertensionMicrovessel mechanobiology in pulmonary arterial hypertension: cause and effectA comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4Plasma levels of S100A4 in portopulmonary hypertensionEvidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes.Idiopathic pulmonary arterial hypertension.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapiesS100A12 mediates aortic wall remodeling and aortic aneurysm.Transcription analysis on response of porcine alveolar macrophages to Haemophilus parasuis.Treating pulmonary arterial hypertension: current treatments and future prospectsEstrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up.Spatiotemporal expression of matrix metalloproteinases (MMPs) is regulated by the Ca2+-signal transducer S100A4 in the pathogenesis of thoracic aortic aneurysm.Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesionsVascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD.Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females.Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema.Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension.Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertensionPulmonary hypertension can be a sequela of prior Pneumocystis pneumonia.Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.Pathogenic mechanisms of pulmonary arterial hypertension.Pulmonary arterial remodeling induced by a Th2 immune responseCritical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.Molecular pathogenesis of pulmonary arterial hypertensionS100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?Signal transduction in the development of pulmonary arterial hypertensionGenetic risk factors for portopulmonary hypertension in patients with advanced liver disease.Pulmonary hypertension: therapeutic targets within the serotonin system.The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.Endothelin receptor antagonists in preclinical models of pulmonary hypertension.Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall.A process-based review of mouse models of pulmonary hypertension.The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension.Experimental and transgenic models of pulmonary hypertension.
P2860
Q24634317-A8932544-A849-46A7-BBF6-412142327B01Q24814603-5D9C18B2-DD03-4B82-9264-F57BB8578E01Q27009717-68D93801-5691-4234-B960-83EA8F1F68BEQ27026643-D9DA60B5-CAAF-476D-9324-ABC71C2AFC3AQ27687091-F9FB4FED-99F2-4A1F-8B54-39FB16A1D624Q33636296-381EC970-2468-4E20-A0A9-BFAAAF977A3CQ33642831-548F8B40-1203-489E-9911-ECB6809DA474Q33811283-86665F66-495D-49BF-A911-7DB62ADB5A03Q33815389-6C86126F-4212-440B-B26A-40657CF6B433Q33849207-95FFBFD4-227F-4BC4-A4D3-491D167ACC26Q33883852-1FFC849E-B0FE-4962-9FC1-E87475ABF17EQ34157917-3CB2AADA-7ADC-4EC4-B04D-C31021C31C13Q34318473-B300EFE0-4BF6-45CE-AAE5-6C5A331EED48Q34524900-D3BF0DC4-3A44-4B1F-AD96-34EF58EED0E0Q34576091-29592427-11DA-4A3F-9150-1B07A5FD5DD8Q34782558-F4344E3E-F606-4A17-A0A5-4C5270C1613AQ34905545-84D8B3F1-9C41-44EE-93EB-2400B8DED8F0Q35168267-9B643272-5CBA-4023-B122-43DFAC6C4303Q35688158-41377379-B434-4A35-A977-C6CC8B68CEB6Q35747729-544BC621-54C1-497D-A214-8C552EBCAB1AQ35813870-66A32633-7D9E-42ED-88EE-B0906E03E253Q35868734-2D7B9E85-1D89-4DD4-A7F2-B567C08D8DB3Q35916976-DD186EDB-4B75-4A19-8B68-3B2CFCEC2F47Q35963236-6753E02E-113D-4AC7-872C-647F6552B201Q35994471-64AF4633-4E09-4E20-A565-A730E12E39FEQ36447388-518984F3-B5FB-4F97-BAB6-D925FA8E263DQ36502869-54772CEB-8F50-4D64-A0C9-5921AD61F7DDQ36701812-73183EA0-7EB7-43BF-B0B0-471F1702EFD1Q36736065-F12BA900-A137-41A0-BDDC-D5B77617E1B9Q37103177-990D9F04-F45E-4E09-B364-B92FF27613C0Q37133785-80E5DB77-07E3-416D-A9AD-932E16B5440FQ37175244-33D76B12-ED6C-4DA9-A4C3-5008B2D9A407Q37184405-F444FB30-3302-4815-8559-EB16AD67C55CQ37346515-C1C791D2-8106-43A1-BAB3-83854ECBE84DQ37428025-EFCDD1AF-6DB0-43D0-832A-25BF213AB8E0Q37475033-173CE881-8025-4A9B-8181-EFC5656A040BQ38078369-EBE1E7A0-7208-4C3A-94AD-DA16A89AF940Q38102555-8F54B1D8-C8A1-42F6-A4A8-CF7409FD375FQ38112038-8EE81B5B-1016-4C4B-9EA9-8B8CB10533DDQ38112056-62300291-9CEF-4904-AE8B-A81ABF2804AD
P2860
S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy
@ast
S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy
@en
type
label
S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy
@ast
S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy
@en
prefLabel
S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy
@ast
S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy
@en
P2093
P2860
P1476
S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy
@en
P2093
Edwin Kwan
Eugene Lukanidin
Gideon Du Marchie Sarvaas
Marlene Rabinovitch
Noona Ambartsumian
Robert Jan van Suylen
Steven Greenway
P2860
P304
P356
10.1016/S0002-9440(10)63115-X
P407
P577
2004-01-01T00:00:00Z